{"name":"OriCell Therapeutics Co., Ltd.","slug":"oricell-therapeutics-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPZDg1Z01CSUR6V0pPTkdnYmFaNEE3NzA1US03VWZJLTg3Y05FTWVpZ0MwS2xaVEFhSXFLMElZbmtrdzUxbEpFTHdiNzBKZDN6enJiZWdLV2tNQjRPaU5qcVJmN0luRlFFNEF1R01nWXVreTl5SUszaDgtNkVtcUx5WFhzUkcyeWk2M1ZrRWUxcERobWZVOTkxTmdadi05Zw?oc=5","date":"2026-03-11","type":"trial","source":"openPR.com","summary":"Advanced Liver Cancer Clinical Trial Pipeline Shows Potential - openPR.com","headline":"Advanced Liver Cancer Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1JY0t5a002UzMwYV91bV9lY0lBRVA4WVZ6T2h0UnE2YWhPTkZhb2k0YlBDQXpXUndQV1RBRXFRd2pkNFAwMWVHc3lzb1ZpS0UyeU8yZjhpVzRfTTV4ZU90MWJ3?oc=5","date":"2026-02-04","type":"pipeline","source":"PharmaTimes","summary":"Thomas Farrell - PharmaTimes","headline":"Thomas Farrell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNQ05DV0U1ci1ISFFRU0JzUHNUY0UyVkNFMlRLXzB3ZEtWREhQLUlOVHk1VHIzUlQtUXpudjJqSFp6MEc4RXNTR1c5WHJ2eWx4YzlWaUMyczN4aDEzYURDcEdvaFppMlBpM1ZCRC00S2tWaXRKOUQxNU0tOHlzb1dzUkJWZFlKMHdha3lXeFJsS2p3SVpUZHR3QjBsTUp5UU5oNGxOQzEyM1pPV0o3M1FjX0tCSXJpeDNuaWE0SUJxaGhCTE50ejJSUVVSd1U?oc=5","date":"2026-01-14","type":"pipeline","source":"BioPharma APAC","summary":"Oricell Raises 70M$ In Series C1 To Advance First In Class CAR T Therapy For Liver Cancer - BioPharma APAC","headline":"Oricell Raises 70M$ In Series C1 To Advance First In Class CAR T Therapy For Liver Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOLXMtZlFJTmRmZVZ4YXA5bEdrVHpwTXMzR1VJallzekU0ZXhmUERqOTctUzh1b3FycmM2Ul9hSDYyUF9lSDZheDh6RTc3ZWF6WXlYaWpSZlFtc01IbFRvX3FLeVVqNzFDZmh1elZwR2F2QmR4RUh4WlJFWEQ1X3dGR3J3bTJ4Q2xkOHZXdVFRbE1rVzU3WktXRlE3T1RJUXQ3UUVmcXJMRUswYlYwRmVhM3JWekUxWWp6RnhTLVA3Rm1NSUJlM2pDclpFbThVMDFrOTFzeWUtaDMtVWFsZkdoMUVyVHpEdTVRakVwbFl6SXMwYjZUS3FRR04xYnNWMEk?oc=5","date":"2025-03-24","type":"pipeline","source":"PR Newswire UK","summary":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight - PR Newswire UK","headline":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxPQnRfVnB4WWZIUWpsb01Ed3hkZkg5cDdkdVZXWUFySUJaMWF6dm04dVZaM0kwOTZPY0toalJCYUxraUJJNUFQSTJjYjBRSDk0RFB0Qk13aktkeXRPeGdYUDVOWEljMnc3dExjVGtjaVY3T2IxVXI4MVNBTjhxa196QXpKeTVvZWU4Y3ZobklhWFpaQ1FQNnRLQjdRMzlfNEZpMURtVTgwNDljWGIzdkxQUVoteEZoRUtUYU9mM2dsNzRoWVFPMFhLNmdaMU41MWNlbTJVUXZZWVh3Y3R3RVF0U3g5VWM2anVsVnd2RUczcnlXVE50bmRBM3lQYkpHeHBnVm5JdGwxVXpDZ0hUQ3o5QWtVLTRzTXM4NE1DTmhCZzAwWURFX2Y3cTl5RmhQaGt0eFE?oc=5","date":"2024-06-05","type":"trial","source":"PR Newswire","summary":"Oricell Presented Long-term Follow-up Data of OriCAR-017 in RRMM at 2024 ASCO Annual Meeting, Highlighting the Sustained Efficacy of GPRC5D CAR-T Therapy - PR Newswire","headline":"Oricell Presented Long-term Follow-up Data of OriCAR-017 in RRMM at 2024 ASCO Annual Meeting, Highlighting the Sustained","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2024-01-29","type":"regulatory","source":"PR Newswire","summary":"Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Mul","headline":"Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNdXZYSVNTX0szU2JkX293X21iYmw3cHdZWFpOMEJZX25CS215T2N2Q24wOTVoaEd5enplNkN6QTVvWWtFYS1LUnVBV1QxVHFYNkVydkxHaEtCazIyZVlwRGQteDNsazcwbEZSQXh5bG81a0FaU0pNV1hUdUdnMjJkag?oc=5","date":"2023-12-20","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNNmxIemcwZTA3UjZoUXNZY0hpcVlFeENPNnhhRVV5amFZSG1kWXdsdWRPTzBGZG9faXZPbXk1Y2V4ME5NWTNJenZYSklnTlFudjdUVkx3VmhiS293dXlKZTAxYmFxbkhvODdiWDNsUmtsQ1RNRUd5aHVlNlczYXpsbUhvV05leTMwT0dxQ2hRdlZJaWFwSC1kbXRSWjdBT2hF?oc=5","date":"2023-09-27","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"6 Immuno-oncology Startups Attracting the Biggest VC Cash - Genetic Engineering and Biotechnology News","headline":"6 Immuno-oncology Startups Attracting the Biggest VC Cash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPblBKdnoydmkySHNIZVlLVlBPSTVIck1GamFyT0FUb2pqZE1kdzRFeFpTZ2VWMDRUWlV3UkV3X1lpM3ZqdnZuRXZ3NExBMlFtZFoxcE8tZ043WENxbXVPeTBiY3VvVXpWLXR4YkhZMFFwejlVR1FLQ3dua0FMb2UxeUxjLUVWcnRxRHBHLVhuQXh0U1pzbnpDMUVfWGh5VWNKZzBIWjFmRnk?oc=5","date":"2023-05-16","type":"deal","source":"BioWorld News","summary":"Lanova licenses ADC candidate for MM to Astrazeneca in $600M deal - BioWorld News","headline":"Lanova licenses ADC candidate for MM to Astrazeneca in $600M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQLURtUVhWeFJTSVpoWnBVY0lYNTlEeWlKZWdFRVY0U2NXSFJOeXZEZ0JvbHdMekhYUk5kcXV1aVF2UHNneG51MGJSOXJJaGEwYW5Id3BCLXNLU0x0UmQwQnZUZHp4clkyOFhKOWVxdHJmWTB2dGtLSTZRTGVHSi16ZS1EbWdSUS1PVl9hMzdNaFYwVi0zWUFFTzZEU1hCeXB2NFBHbndWMjhXVm92UlZ6NnBMclVXRnI0cFJnMVAzT2pNdnlzNzFDMldDQzEydnVxWUhz?oc=5","date":"2022-08-04","type":"pipeline","source":"BioSpectrum Asia","summary":"OriCell Therapeutics raises over $120 M to advance cell therapies for cancer immunology - BioSpectrum Asia","headline":"OriCell Therapeutics raises over $120 M to advance cell therapies for cancer immunology","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}